Abstract
AIDS is having a dramatic effect on our society. As a result, a consumer movement has been formed which is seeking to change the way drugs are tested and used. In response, the FDA has slowly begun to make some changes in its drug policies. This paper documents the policy battle that is underway and suggests that it may lead to a shift in health care policy extending beyond AIDS to all diseases. Implications and recommendations are also considered.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
